This is a fascinating development because AI models may turn out to be like pharmaceuticals. The first pill costs $500 million to make, the second one costs pennies.
Companies are still charging 100x for the pills that cost pennies to produce.
Besides deals with insurance companies and governments, one of the ways that they are still able to pull this is convincing everyone that it's too dangerous to play with this at home or buying it from an Asian supplier.
At least with software we had until now a way to build and run most things without requiring dedicated super expensive equipment. OpenAI pulled a big Pharma move but hopefully there will be enough disruptors to not let them continue it.
The solution is to create a health insurance system which burdens only Americans with the $500m cost, while India is allowed to make the drug for pennies for the rest of the world.
